4 research outputs found
Recurrent intermammary pilonidal sinus: a rare case with literature review.
No full textIntroduction: the usual area for pilonidal sinus disease is the sacrococcygeal region. The aim of this study is to report an extremely rare condition of recurrent intermammary pilonidal disease with a brief literature review.
Case report:
A 22 -year-old married lady complained of discharge, pain, and redness in the intermammary region for 1 year. On examination, there is a single discharging sinus and an old scar around it. Excisional biopsy confirmed the diagnosis of pilonidal sinus.
Conclusion: However its rare, intermammary pilonidal sinus may recur and require surgical re-intervention
Lists of predatory journals and publishers: a review for future refinement
No full textAlthough predatory publishers are increasingly recognized, universally accepted criteria for defining predatory journals are lacking. These journals challenge the scholarly community by blurring the line between legitimate and questionable publishing practices. Several lists and reports of predatory journals have been published, which offer valuable insights; however, they are not devoid of criticism. Beall’s list, although criticized for its inclusion criteria, is currently managed anony-mously and updated infrequently. Cabells’ list uses an extensive array of inclusion criteria, some of which are similar to those used in Beall’s list. Several of these cri-teria are redundant and fail to detect predatory practices, and using all of them in evaluating a journal is seldom practicable. Kscien’s list has emerged as a promising alternative for identifying predatory publishers or journals. However, it requires refinement, potentially through creating a distinct list supported by unequivocal evidence, such as accepting a fake manuscript (ascertained through a sting opera-tion). The present review seeks to catalyze research on identifying predatory jour-nals and publishers by comparing existing lists and suggesting new techniques for detecting predatory practices
Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
No full textBackground: Cardiovascular diseases (CVDs) are the leading cause of mortality and are among the foremost causes of disability globally. CVD burden has continued to increase in most countries since 1990, with trends driven by changing exposures to harmful risk factors, population growth, and population aging. Objectives: We report estimates of global, national, and subnational CVD burden, including 18 subdiseases and 12 associated modifiable risk factors. We analyzed change in CVD burden from 1990 to 2023 and identified drivers of change including population growth, population aging, and risk factor exposure. Methods: The Global Burden of Disease (GBD) 2023 study, a multinational collaborative research study, quantified burden due to 375 diseases including CVD burden and identified drivers of change from 1990 to 2023 using all available data and statistical models. GBD 2023 estimated the population-level burden of diseases in 204 countries and territories from 1990 to 2023. Results: CVDs were the leading cause of disability-adjusted life years (DALYs) and deaths estimated in the GBD. As of 2023, there were 437 million (95% UI: 401 to 465 million) CVD DALYs globally, a 1.4-fold increase from the number in 1990 of 320 million (292 to 344 million). Ischemic heart disease, intracerebral hemorrhage, ischemic stroke, and hypertensive heart disease were the leading cardiovascular causes of DALYs in 2023 globally. As of 2023, age-standardized CVD DALY rates were highest in low and low-middle Socio-demographic Index (SDI) settings and lowest in high SDI settings. The number of CVD deaths increased globally from 13.1 million (95% UI: 12.2 to 14.0 million) in 1990 to 19.2 million (95% UI: 17.4 to 20.4 million) in 2023. The number of prevalent cases of CVD more than doubled since 1990, with 311 million (95% UI: 294 to 333 million) prevalent cases of CVD in 1990 and 626 million (95% UI: 591 to 672 million) prevalent cases in 2023 globally. A total of 79.6% (95% UI: 75.7% to 82.5%) of CVD burden is attributable to modifiable risk factors 347 million [95% UI: 318 to 373 million] DALYs in 2023). Globally, high systolic blood pressure, dietary risks, high low-density lipoprotein cholesterol, and air pollution were the modifiable risks responsible for most attributable CVD burden in 2023. Since 1990, changes in exposure to modifiable risk factors have had mixed effects on CVD burden, with increases in high body mass index, high fasting plasma glucose, and low physical activity leading to higher burden, while reductions in tobacco usage have mitigated some of these increases. Population growth and population aging were the main drivers of the increasing burden since 1990, adding 128 million (95% UI: 115 to 139 million) and 139 million (95% UI: 126 to 151 million) CVD DALYs to the increase in CVD burden since 1990. Conclusions: CVD remains the leading cause of disease burden and death worldwide with the greatest burden in low, low-middle, and middle SDI regions. Large variation exists in CVD burden even for countries at similar levels of development, a gap explained substantially by known, modifiable risk factors that are inadequately controlled. The decades-long increase in CVD burden was the result of population growth, population aging, and increased exposure to a subset of risk factors led by metabolic risks. Countries will need to adopt effective health system and public health strategies if they are to progress in achieving global goals to reduce the burden of CVD
